Anu Pansare has joined the local gBETA team. Photo via gbetastartups.com

Houston's gBETA accelerator announced new leadership in conjunction with opening enrollment for its latest cohort this week.

The early-stage program, which is a part of Wisconsin-based gener8tor, has named Anu Pansare as its new director.

Pansare has spent the last 20 years at Sugar Land-based consulting firm Volyx and has also worked with big names like Chevron, Schlumberger, and Accenture, as well as smaller startups. She's also been involved with the Houston Angel Network. She will be replacing the accelerator's inaugural director Eléonore Cluzel in the position.

As the main liaison between Houston and gener8tor's national network, Pansare will lead gBETA's third cohort of early stage startups through its free 7-week program, which is designed to help participating companies gain early customer traction and develop key metrics that will make them more marketable for future investment.

"Downtown Launchpad is an inclusive ecosystem of tools, resources, and opportunities that help founders accelerate and scale their businesses to solve humankind's boldest challenges," says Robert Pieroni, director of economic development at Central Houston, in a press release. "The addition of Anu Pansare as gener8tor's new Houston director will strengthen our commitment to entrepreneurs in Houston and will help us evolve our strategy to better serve our founders, startups, partners, and our community."

Applications for the new cohort are open online until March 13.The zero-equity, no-fee program looks for locally based startups still in the early stage of business. Five companies will be selected.

The program is hosting a virtual webinar in partnership with SCORE Houston on March 1 to discuss the program and opportunities for interested startups. Event registration is free.

Houston's gBETA presence was launched thanks to a $1.25 million grant approved by the Downtown Redevelopment Authority in 2019 with support from Central Houston, the City of Houston, and Amegy Bank. The local team has an office at the Downtown Launchpad coworking space in the Amegy Bank Building on Main.

About a year into operations, gBETA has worked with 10 local startups in two cohorts across industries — from food tourism to sports technology, artificial intelligence for home buying to skincare and prescription solutions.

Pansare will be holding virtual office hours for local entrepreneurs to provide insight and information about gBETA's Houston Spring 2021 program. More information on the program can be found at gBETA Houston's website or email Pansare directly at anu@gener8tor.com.
This week's roundup of Houston innovators includes Niloufar Molavi of Central Houston Inc., Dan Purvis of Velentium, and Chris Staffel of Goose Capital. Courtesy photos

3 Houston innovators to know this week

who's who

Editor's note: In the week's roundup of Houston innovators to know, I'm introducing you to three innovators — each either new to their role or with a bit of acquistion news.

Niloufar Molavi, board chair at Central Houston Inc.

Niloufar Molavi will lead Central Houston Inc.'s board this year — and she's got fostering innovation on her to-do list. Photo courtesy of CHI

Last week, Nilofar Molavi assumed the role of board chair for Central Houston. She leads PwC's Global energy practice and has served on the CHI board since 2011 and chairs the organization's innovation committee. CHI was among the partners behind the Downtown Launchpad, a 17,000-square-foot innovation hub, which had its grand opening last fall.

"With the fall 2020 opening of Downtown Launchpad, we have deepened our investment in innovation, which we hope will garner long-term results and economic vitality for downtown as well as the Houston region at large," she continues. "We look forward to developing bridge programs with area universities and organizations and leveraging existing resources to bring more high-tech prospects to our central city." Read more.

Dan Purvis, CEO of Velentium

A Houston company has made a strategic acquisition. Photo courtesy of Velentium

Houston-based Velentium, which specializes in the design and manufacturing of medical devices announced that it has acquired Texas company Oasis Testing, a designer of automated test systems for the energy and manufacturing industries.

"Despite the immense challenges facing the business community in 2020, last year was a monumental year of growth for our firm, and we're pleased to start 2021 building upon our world-class team of technical experts," says Dan Purvis, CEO of Velentium, in a news release. "Oasis Testing has been a trusted partner for the last five years and shares in our commitment to solving clients' most complex challenges to change lives for a better world. We're incredibly excited to welcome them to the Velentium family and expand our business more deeply into energy and manufacturing."

Purvis will lead the new combined company as CEO. Read more.

Chris Staffel, managing director at Goose Capital

Goose Capital recently named its new managing director. Photo courtesy of Chris Staffel

Houston-based investment group Goose Capital Inc. named Chris Staffel as managing director — along with Jeff Smisek as the firm's president and Jay Collins as chair of the board of directors.

A serial entrepreneur and investor in over 30 startups, Staffel joins Goose to lead day-to-day operations and drive new investment opportunities.

"It is an honor to join the team at Goose Capital and work alongside experienced industry leaders," Staffel says in the release. "I look forward to leveraging my entrepreneurial experience to help the start-ups in which we invest, while strategically identifying early stage investment opportunities." Read more.

The 1550 on the Green tower will anchor a new mixed-use district. Rendering courtesy of Skanska

New downtown office tower will rise in bustling Discovery Green

new to hou

A new office tower will soon loom over the popular Discovery Green as the anchor of a new downtown district. Global development and construction firm, Skanksa, announced the new building at 1550 Lamar St. and its anchor tenant on January 13. The new 28-story, 375,000-square-foot Class-A office structure is dubbed 1550 on the Green, per a Skanska statement.

Global law firm Norton Rose Fulbright will relocate its Houston office in 2024 and acquire naming rights upon occupancy, according to a press release.

Bound by La Branch, Lamar, Crawford, and Dallas Streets, 1550 on The Green will feature extra-wide pedestrian zones with a canopy of trees, two tenant outdoor roof terraces, and wide views of the surrounding greenery.

International design firm BIG-Bjarke Ingels Group led the building's design; it is the company's first foray into Texas. BIG's design promises sustainability, energy efficiency, and an "airy" office environment for tenants, a release describes.

Some 7,000 square feet of retail space will greet first-floor guests. Michael Hsu Office of Architecture has been tapped to design the interior amenity spaces; those include a fitness center, rooftop event space and terrace, and community spaces.

The new 1550 on the Green tower is part of a new envisioned district that will be branded as Discovery West. The district will consist of 3.5 acres of mixed-use development boasting restaurants, retail, green space, and "world-class architecture," per a release.

Working with Central Houston Inc., Discovery Green, Bike Houston, the Kinder Foundation, as well as several brokers, Skanska and design firm of record, BIG-Bjarke Ingels Group, completed the master plan for Discovery West in early 2020.

Skanska has been noticeably active in the Houston office market, specifically with the development of Bank of America Tower, West Memorial Place I and II, and the future Discovery West. The company is behind the acquisition of a buzzy strip center in Montrose. Skanska also plans to multifamily to its Houston portfolio, the firm notes.

"As an organization that prides itself on building what matters to our communities, our team, made up of Houstonians, has been working alongside local stakeholders to develop a plan and a building that will transform this side of downtown Houston while still meeting the needs of the city," said Matt Damborsky, executive vice president for Skanska USA commercial development's Houston market, in a statement.

------

This article originally ran on CultureMap.

Niloufar Molavi will lead Central Houston Inc.'s board this year — and she's got fostering innovation on her to-do list. Photo courtesy of CHI

Houston organization names new leader to focus on innovation and economic development

now in charge

An organization that promotes redevelopment and revitalization in Houston has named its new board leader for 2021.

Niloufar Molavi, partner at PwC US, has assumed Central Houston Inc.'s board leadership role effective January 8. Molavi, who leads PwC's Global energy practice, has served on the CHI board since 2011 and chairs the organization's innovation committee.

"Over more than a decade serving on the CHI board, I have witnessed first-hand the major changes that the organization has affected in downtown," Molavi says in a news release. "Among our 2021 priorities is to continue to foster the growth of the innovation sector."

In October, CHI — along with its partners, Amegy Bank and the Downtown Redevelopment Authority — celebrated the grand opening of the Downtown Launchpad, a 17,000-square-foot innovation hub located on the 10th floor of Amegy on Main (1801 Main Street). The hub is home to Houston's MassChallenge Texas and gener8tor accelerators and global nonprofit incubator Impact Hub Houston. The Cannon Houston is the operation partner for the space.

"With the fall 2020 opening of Downtown Launchpad, we have deepened our investment in innovation, which we hope will garner long-term results and economic vitality for downtown as well as the Houston region at large," she continues. "We look forward to developing bridge programs with area universities and organizations and leveraging existing resources to bring more high-tech prospects to our central city."

Molavi, as board chair, will focus on near-term and long term strategic priorities for CHI, which include the region's economic recovery following the pandemic, improving transportation, further developing the innovation ecosystem, recruiting new employers to downtown, and more.

Central Houston Inc. and its Downtown Launchpad recently took home a couple big wins. Photo courtesy of CHI

New innovation center in downtown Houston receives international recognition

big winner

A Houston organization has been recognized for a newly opened innovation hub in downtown.

The International Economic Development Council has awarded Central Houston Inc.'s Downtown Launchpad two honors in its Excellence in Economic Development Awards Program. The new 17,000-square-foot innovation hub in Southern Downtown won a silver rank in the awards' Innovation Programs and Initiatives category and a bronze rank in the Entrepreneurship category.

"The creation of a vibrant innovation district in Downtown has been a strategic priority for Central Houston since it was identified in the 2017 Plan Downtown, our 20-year vision plan for the area's growth and development," says Bob Eury, CHI president, in a news release.

"Downtown Launchpad, which opened just last month, achieves our goal of strengthening connections between entrepreneurs, industry, startups and funders, and we're honored to see the hard work of Central Houston, Inc. and our partners recognized by the International Economic Development Council."

IEDC received over 500 submissions for 35 categories for this year's award. Each submission was evaluated by a diverse panel of economic and community developers from around the world and were looking at the nominees' efforts in creating positive change in urban, suburban and rural communities.

"The winners of IEDC's Excellence in Economic Development awards represent the very best of economic development and exemplify the ingenuity, integrity and leadership that our profession strives for each and every day," says the 2020 IEDC Board Chair and One Columbus CEO Kenny McDonald in the release. "We're honored to recognize the more than 100 communities whose marketing campaigns, projects and partnerships have measurably improved regional quality of life."

Last month, the Downtown Launchpad celebrated its grand opening. The hub is located on the 10th floor of Amegy on Main (1801 Main Street), is home to Houston's MassChallenge Texas and gener8tor accelerators and global nonprofit incubator Impact Hub Houston. The Cannon Houston is the operation partner for the space.

The Downtown Launchpad is officially open for business. Photo courtesy of the Downtown Launchpad

Innovation space in downtown Houston celebrates its grand opening

now open

Almost exactly a year ago, Central Houston Inc. and the Downtown Redevelopment Authority announced the Downtown Launchpad to emerge as a "vertical village" of innovation space. Now, as of this week, the new space has been revealed at its official grand opening.

The 17,000-square-foot innovation hub, which is located on the 10th floor of Amegy on Main (1801 Main Street), is home to Houston's MassChallenge Texas and gener8tor accelerators and global nonprofit incubator Impact Hub Houston. The Cannon Houston is the operation partner for the space.

"Downtown Launchpad innovation hub starts at the edges of technology and entrepreneurship where cutting-edge ideas can quickly be cultivated and explored," says Bob Eury, president of Central Houston and Downtown Redevelopment Authority, in a news release. "We set out to recruit and develop partnerships with some of the nation's premier accelerators and incubators in order to build an inclusive vertical village with all the critical support functions just steps away. We are excited and look forward to the impact created by the hundreds of startups that will walk through our doors."

The "vertical village" features coworking and accelerator space. Photo courtesy of the Downtown Launchpad

The new space, which has been partially open since last December, celebrated the opening with a virtual event and panel on September 30. Mayor Sylvester Turner joined the programming to recognize the Launchpad.

"To meet the challenges of today, we must empower a can-do spirit by offering a framework of resources that includes supporting startups and entrepreneurs as they seamlessly navigate through the stages of startup production — from idea generation and incorporation to talent development, investment, and scaling, as well as ensuring upskilling and reskilling to provide economic vitality for all Houstonians," Mayor Turner says at the event. "Downtown Launchpad enables this to happen. Hundreds of new businesses will be built here in the coming years."

The space, which will be used for programming and events, features a communal ground-floor lobby area with meeting rooms, a game room, workstations, and a coffee bar and deli, according to the release. There's also a dedicated event space on the building's 11th floor.

Common space are designed to enhance collisions between entrepreneurs. Photo courtesy of the Downtown Launchpad

"In the 2017 Plan Downtown, a key business strategy focuses on facilitating the creation of a collaborative Innovation District within Downtown," says Curtis Flowers, Downtown Redevelopment Authority board chair, in the release. "The purpose is to incubate a vibrant, innovative economy where startups thrive, create jobs, and attract venture capital investments to Houston which will benefit the City's long-term economic vitality. We believe the investment in establishing Downtown Launchpad will garner long-term results for Downtown and the Houston region."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.